ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,009, issued on Nov. 3, was assigned to Novacell Technology Inc. (Seoul, South Korea).
"Pharmaceutical composition for treating dry eye syndrome" was invented by Jae Wang Ghim (Pohang-si, South Korea), Tae Hoon Lee (Seoul, South Korea) and Hyun Ju Lee (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a novel pharmaceutical composition for treating dry eye syndrome. The composition significantly alleviates corneal damage and corneal opacity without side effects, thereby restoring damaged corneas and increasing tear secretion, and thus effectively treats ophthalmic diseases related to dry eye syndrome."
T...